These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20561311)

  • 1. Quality of life assessment in HIV clinical research in resource-limited settings: better late than never.
    Becquet R; Burgos-Soto J; Carrieri MP; Spire B
    Trop Med Int Health; 2010 Sep; 15(9):1008-10. PubMed ID: 20561311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the ART: clinical efficacy and improved quality of life in the public antiretroviral therapy program, Free State province, South Africa.
    Wouters E; Van Loon F; Van Rensburg D; Meulemans H
    AIDS Care; 2009 Nov; 21(11):1401-11. PubMed ID: 20024717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities and options for treatment research in resource-constrained settings.
    Volberding PA
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S1-3. PubMed ID: 12822126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age.
    Sauvageot D; Schaefer M; Olson D; Pujades-Rodriguez M; O'Brien DP
    Pediatrics; 2010 May; 125(5):e1039-47. PubMed ID: 20385636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection and advanced age emerging epidemiological, clinical, and management issues.
    Manfredi R
    Ageing Res Rev; 2004 Jan; 3(1):31-54. PubMed ID: 15164725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV antiretroviral drug resistance in Africa.
    Nkengasong JN; Adje-Toure C; Weidle PJ
    AIDS Rev; 2004; 6(1):4-12. PubMed ID: 15168736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV care and treatment for children in resource-limited settings.
    Callens SF; McKellar MS; Colebunders R
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):181-90. PubMed ID: 18380600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.
    Bélec L; Bonn JP
    Future Microbiol; 2011 Nov; 6(11):1251-60. PubMed ID: 22082287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment for HIV infection: 2005 recommendations].
    De Wit S
    Rev Med Brux; 2005 Sep; 26(4):S378-81. PubMed ID: 16240890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early treatment of HIV: implications for resource-limited settings.
    Hobbs CV; Essajee SM
    Curr Opin HIV AIDS; 2009 May; 4(3):222-31. PubMed ID: 19532054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV resistance and the developing world.
    Gupta RK; Pillay D
    Int J Antimicrob Agents; 2007 May; 29(5):510-7. PubMed ID: 17346940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
    Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention?
    Menon S
    J Public Health Policy; 2010 Dec; 31(4):385-400. PubMed ID: 21119646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
    Kent DM; McGrath D; Ioannidis JP; Bennish ML
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S13-24. PubMed ID: 12822128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertically acquired paediatric HIV infection: the challenges of providing comprehensive packages of care in resource-limited settings.
    Little KE; Bland RM; Newell ML
    Trop Med Int Health; 2008 Sep; 13(9):1098-110. PubMed ID: 18664240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a human immunodeficiency virus/acquired immunodeficiency syndrome therapeutic research agenda for resource-limited countries: a consensus statement.
    Vermund SH; Powderly WG; ;
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S4-12. PubMed ID: 12822127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral treatment in resource-poor settings: public health research priorities.
    Jaffar S; Govender T; Garrib A; Welz T; Grosskurth H; Smith PG; Whittle H; Bennish ML
    Trop Med Int Health; 2005 Apr; 10(4):295-9. PubMed ID: 15807791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indicators of adherence to antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries.
    Etienne M; Hossain M; Redfield R; Stafford K; Amoroso A
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):98-103. PubMed ID: 20207981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.